CAPTRUST Financial Advisors
BIOR

CAPTRUST Financial Advisors’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

CAPTRUST Financial Advisors’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-9
Closed -$2K – 4531
2022
Q2 		$2K Hold
9
– – ﹤0.01% 4566
2022
Q1 		$3K Hold
9
– – ﹤0.01% 4425
2021
Q4 		$5K Buy
+9
New +$6.46K ﹤0.01% 4119

Other funds holding BIOR

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

CAPTRUST Financial Advisors's BIOR Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q3 2022, closing a stake of 9 shares — an estimated $2K sold.

CAPTRUST Financial Advisors first reported a position in BIOR in Q4 2021 and held it in 3 quarters. The position peaked at $5K in Q4 2021. 44 funds tracked by Wall St. Rank hold BIOR as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 9 Biora Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $2K.
  • CAPTRUST Financial Advisors first reported a position in Biora Therapeutics, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • CAPTRUST Financial Advisors's Biora Therapeutics, Inc. Common Stock position peaked at $5K in Q4 2021.
  • 44 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.